Mitesco consolidates compound pharmacy services for human and veterinary health while innovating in cloud computing and secure data center solutions. The company is focused on developing a portfolio of companies that provide healthcare technology solutions and the team is adept at deal structures supportive of long-term organizational value.
Cyborg Score Rationale
Mitesco operates as a micro-cap OTC stock with limited analyst coverage, small market capitalization ($3.6M as of mid-2025), and diversified but fragmented business operations spanning clinical care, pharmaceuticals, and technology with unclear integration strategy.
Top Insights
Company changed its name from True Nature Holding, Inc. to Mitesco, Inc. in April 2020, repositioning toward healthcare technology
MITI exceeded both the US Healthcare industry (-21.4%) and US Market (10.6%) returns over the past year, though from a very small base
Weekly volatility decreased from 61% to 36% over the past year but remains higher than 75% of US stocks
Company is covered by only 1 analyst, with limited earnings or revenue estimates available
Named Competitors
MinuteClinic — Urgent care and primary care clinics
AWS — Cloud computing and data center services
Azure — Cloud infrastructure and hosting
Recent Developments
(October 2025) Senior Secured 5% Original Issue Discount Promissory entered
(August 2025) Appointment of new executive to leadership
(June 2025) Progress announced on Robo-Agent A.I. for Real Estate
Open the full interactive Mitesco, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.